Paclitaxel-Coated Versus Sirolimus-Coated Eluting Balloons for Percutaneous Coronary Interventions: Pharmacodynamic Properties, Clinical Evidence, and Future Perspectives

Paclitaxel-Coated Versus Sirolimus-Coated Eluting Balloons for Percutaneous Coronary Interventions: Pharmacodynamic Properties, Clinical Evidence, and Future Perspectives

Drug-coated balloons (DCBs) have emerged as an increasingly valuable option for the treatment of coronary artery disease (CAD). Percutaneous coronary intervention (PCI) with DCBs enables the localized delivery of antiproliferative drugs directly to the target coronary lesion, avoiding the need for p...

Full description

Bibliographic Details
Main Authors: Filippo Luca Gurgoglione, Mattia De Gregorio, Giorgio Benatti, Davide Donelli, Luigi Vignali, Emilia Solinas, Iacopo Tadonio, Andrea Denegri, Marco Covani, Gabriella Dallaglio, Bernardo Cortese, Giampaolo Niccoli
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Future Pharmacology
Subjects:
drug-coated balloon
paclitaxel
sirolimus
angioplasty
coronary artery disease
peripheral artery disease
Online Access:https://www.mdpi.com/2673-9879/4/4/41

Internet

https://www.mdpi.com/2673-9879/4/4/41

Similar Items